cancer
Conditions
Interventions
None listed
Sponsors
National Cancer Center Hospital East
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1) The participant must have participated in the CONDUCTOR study as of March 2025, have not withdrawn consent, and have not refused secondary use of the information or sample. 2) Participants in the CONDUCTOR study must be at least 18 years old. 3) You have participated in the "Tohoku Medical Megabank Project Three Generations Cohort Study" or "Tohoku Medical Megabank Project Community Cohort Study" (hereinafter referred to as "ToMMo") between May 2013 and March 2025, have not withdrawn your consent, and have not refused secondary use of information and samples. In addition, if blood samples are to be collected for a clinical performance study, written consent for participation in this study has been obtained from the individual based on his/her voluntary will. 4) There is no history of malignancy in the ToMMo main body study participants in 3). 5) The ToMMo main study participant in 3) must be between 20 and 75 years of age.
Exclusion criteria
Exclusion criteria: The person in charge of this research is judged as not having sufficient ability to make decisions regarding the implementation of this research.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To evaluate the clinical performance (sensitivity, specificity, etc.) of the developed MRD and MCED assays | — |
Secondary
| Measure | Time frame |
|---|---|
| To evaluate the clinical performance (sensitivity, specificity, etc.) of the developed MRD and MCED assays by cancer type, clinical stage, etc. | — |
Countries
Japan
Contacts
Public ContactTaro Shibuki
National Cancer Center Hospital East Department for the Promotion of Drug and Diagnostic Development
Outcome results
None listed